We are live on ! Find out more
NBP

NovaBridge Biosciences American Depositary Shares

65 hedge funds and large institutions have $616M invested in NovaBridge Biosciences American Depositary Shares in 2020 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 22 increasing their positions, 5 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

340% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 5

300% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 6

38% more capital invested

Capital invested by funds: $447M → $616M (+$168M)

35% more funds holding

Funds holding: 4865 (+17)

2.18% more ownership

Funds ownership: 5.88%8.06% (+2.2%)

20% less funds holding in top 10

Funds holding in top 10: 54 (-1)

Holders
65
Holders Change
+17
Holders Change %
+35.42%
% of All Funds
1.15%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.07%
New
24
Increased
22
Reduced
5
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Lord, Abbett & Co
26
Lord, Abbett & Co
New Jersey
$3.28M +$2.74M +69,570 New
Fidelity Investments
27
Fidelity Investments
Massachusetts
$2.49M +$13.7K +347 +0.7%
VIA
28
Vident Investment Advisory
Georgia
$2.48M +$1.73M +44,059 +519%
MS
29
Maven Securities
Jersey
$2.09M +$1.75M +44,411 New
Allianz Asset Management
30
Allianz Asset Management
Germany
$1.83M +$748K +18,985 +95%
Franklin Resources
31
Franklin Resources
California
$1.65M
EMG
32
ETF Managers Group
New Jersey
$1.45M +$74.1K +1,882 +6%
Millennium Management
33
Millennium Management
New York
$1.44M +$1.03M +26,123 +597%
Norges Bank
34
Norges Bank
Norway
$1.42M
LCAM
35
Long Corridor Asset Management
Hong Kong
$1.42M +$1.18M +30,000 New
Two Sigma Investments
36
Two Sigma Investments
New York
$1.11M +$930K +23,618 New
Citigroup
37
Citigroup
New York
$990K +$826K +20,989 New
BFM
38
Boothbay Fund Management
New York
$836K +$75.4K +1,915 +12%
Goldman Sachs
39
Goldman Sachs
New York
$755K -$1.61M -40,899 -72%
State Street
40
State Street
Massachusetts
$721K +$602K +15,292 New
SCM
41
Sio Capital Management
New York
$707K
Invesco
42
Invesco
Georgia
$641K +$251K +6,365 +88%
HSBC Holdings
43
HSBC Holdings
United Kingdom
$640K +$118 +3 +0%
NSRI
44
New Silk Road Investment
Singapore
$566K
Geode Capital Management
45
Geode Capital Management
Massachusetts
$494K +$203K +5,154 +97%
SFI
46
Susquehanna Fundamental Investments
Pennsylvania
$450K
Jane Street
47
Jane Street
New York
$407K +$340K +8,634 New
JF
48
Jump Financial
Illinois
$370K +$101K +2,556 +48%
VEA
49
Virtus ETF Advisers
New York
$364K +$304K +7,725 New
MWNA
50
Marshall Wace North America
New York
$356K +$298K +7,564 New

NBP Hedge Fund Activity: Q4 2020 in Review

65 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q4 2020, worth a combined $616M — up 38% from $447M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new NBP positions and 6 closed out — a net gain of 18 holders — while 22 added to existing stakes and 5 trimmed.

The largest buyer was Cederberg Capital, opening a new position worth an estimated $70M. The largest seller was Manulife (Manufacturers Life Insurance), cutting an estimated $7.61M.

  • 65 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q4 2020, up from 48 in Q3 2020.
  • Funds reported $616M of NovaBridge Biosciences American Depositary Shares stock for Q4 2020, up 38% quarter-over-quarter.
  • 24 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q4 2020 and 6 closed out, a net change of +18 holders.
  • The largest NovaBridge Biosciences American Depositary Shares buyer in Q4 2020 was Cederberg Capital, an estimated $70M added.
  • The largest NovaBridge Biosciences American Depositary Shares seller in Q4 2020 was Manulife (Manufacturers Life Insurance), an estimated $7.61M sold.

Based on aggregated 13F filings for Q4 2020.